About Drupal 8
Have you ever felt that your website needs to be more personalized, integrated with cutting-edge technology to offer enhanced user experience?
Valuebound is one of those companies, which specifically help organizations in their path to digital transformation. We enhance digital experience for end users with tailored web applications.
Recent releases
|
Creating Accessible Websites with Drupal: Tips from the Leader
Learn how to create accessible websites with Drupal! Get tips and insights from Valuebound’s leader. Improve user experience for all.
|
Using Drupal Entity Reference to Enhance Data Management
Learn how to use Drupal's Entity Reference module to manage and organize your data more efficiently. Improve your content creation and site management with this powerful tool.
|
Valuebound Hosts Successful Drupal Meetup 2023 in Bangalore
Valuebound's recent Drupal Meetup in Bangalore was a success! Learn about the insightful sessions and opportunities for networking and collaboration.
|
Women’s Day Blog Series: Everything you wanted to know about Women technologists at Valuebound
Discover the inspiring stories and insights of women technologists at Valuebound this Women's day 2023. From overcoming challenges to achieving success, learn everything about women in tech and…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
